In 1996, when RMP - 7 was first
used on brain cancer patients in a Phase 1 clinical trial at UCLA, it was found to be safe, with virtually no side effects.
This page features
information on brain cancer and immunotherapy clinical trials for brain cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based treatments to people with brain cancer.
Genome Atlas Group
Reports on Brain Cancer Genes Johns Hopkins Kimmel Cancer Center investigators were part of The Cancer Genome Atlas (TCGA) which reported results from its first comprehensive study focused on the deadly brain cancer glioblastoma.
I really enjoy and benefit the many podcasts that Phil has done and would love to hear your thoughts and
info on brain cancer.